[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:unconventional-myosin-ig":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Unconventional Myosin-Ig",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05473910","A Phase 1\u002F3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA-2)",[11],"Phase 1","RECRUITING","2026-08-26T02:16:50.548894Z","2026-07-19T19:36:05.117931Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT07702578","A Phase 1-3 Study of T-Cell Receptor Engineered Donor T Cells in Subjects Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation (ALLOHA-2)",[19],"Phase 3","2026-08-26T02:18:04.640417Z","2026-07-19T19:36:05.086207Z"]